<DOC>
	<DOCNO>NCT01711866</DOCNO>
	<brief_summary>The purpose study assess safety feasibility switch subject advance Parkinson 's Disease ( PD ) Pramipexole Ropinirole Rotigotine ass effect Rotigotine motor non-motor symptom Parkinson 's Disease subject switch previous treatment either Pramipexole Ropinirole .</brief_summary>
	<brief_title>A Phase 4 , Open-label Study Assess Feasibility Efficacy Motor Non-motor Symptoms Switching From Pramipexole Ropinirole Rotigotine Transdermal Patch Subjects With Advanced Idiopathic Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Ropinirole</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<mesh_term>N 0437</mesh_term>
	<criteria>Subject idiopathic Parkinson 's Disease 3 year duration , define cardinal sign , bradykinesia , plus presence least 1 follow : rest tremor , rigidity , impairment postural reflex without know suspected cause Parkinsonism Subject motor fluctuation Subject satisfactorily control follow investigatorÂ´s assessment total daily dose Pramipexole Ropinirole Subject sleep disturbance early morning motor impairment Subject experience nocturia least 3 night within 7 day prior Baseline Visit Subject take Ldopa combination Benserazide Carbidopa stable dose Ldopa least 28 day prior Baseline Visit Subject therapy Tolcapone Budipine Subject receive therapy one follow drug either concurrently within 28 day prior Baseline ( Visit 2 ) : alphamethyl dopa , metoclopramide , reserpine , neuroleptic , monoamine oxidase A ( MAOA ) inhibitor , methylphenidate , amphetamine Subject history symptomatic ( asymptomatic ) orthostatic hypotension 6 month prior Baseline ( Visit 2 ) Subject history significant skin hypersensitivity adhesive transdermal preparation , recent unsolved contact dermatitis Subject history seizure stroke within 1 year , history myocardial infarction within last 6 month prior enrollment Subject pregnant nursing , childbearing potential ( ) surgically sterile ( ii ) use adequate birth control method ( include least 1 barrier method ) ( iii ) sexually abstinent ( iv ) least 2 year postmenopausal Subject previous diagnosis narcolepsy , sleep apnea syndrome , restless legs syndrome , periodic limb movement disorder</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Rotigotine</keyword>
	<keyword>Neupro</keyword>
	<keyword>Switch</keyword>
	<keyword>Dopamine agonist</keyword>
</DOC>